Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04280562 · ClinicalTrials.gov registry record · NA
Remote Participation (Within USA) Trial of Sana Pain Reliever
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT04280562 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 75 participants.
The verdict
NCT04280562, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
Randomized controlled trial to assess the effectiveness and patient perception of the benefit of the Sana Pain Reliever in individuals with chronic neuropathic pain.The study is fully remote with four study visits taking place over teleconferencing and the study devices mailed to the participants to use at home for 8-14 weeks.
Interventions
- DEVICE Sana Pain Reliever
- DEVICE Sham SPR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-01-31 |
| Est. Completion | 2023-02-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04280562
The ClinicalTrials.gov registry entry for NCT04280562 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sana Pain Reliever is the first listed.
NCT04280562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04280562 about?
NCT04280562 is a clinical study titled "Remote Participation (Within USA) Trial of Sana Pain Reliever". Randomized controlled trial to assess the effectiveness and patient perception of the benefit of the Sana Pain Reliever in individuals with chronic neuropathic pain.The study is fully remote with four study visits taking place over teleconferencing and the study devices mailed to the participants to...
What is the current status of trial NCT04280562?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2020-01-31. Estimated completion is 2023-02-21.
What interventions are being tested in trial NCT04280562?
The interventions under investigation include: Sana Pain Reliever (DEVICE), Sham SPR (DEVICE).
Who is sponsoring clinical trial NCT04280562?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.